Rethinking protein aggregation and drug discovery in neurodegenerative diseases: Why we need to embrace complexity?

Title
Rethinking protein aggregation and drug discovery in neurodegenerative diseases: Why we need to embrace complexity?
Authors
Keywords
Neurodegenerative diseases, Neurodegeneration, Pathological aggregates, Post-translational modifications, Amyloid, Fibrils, Cryo-EM, Amyloid-beta, Alpha-synuclein, Tau, TAR DNA-binding protein 43, TDP-43
Journal
CURRENT OPINION IN CHEMICAL BIOLOGY
Volume 64, Issue -, Pages 67-75
Publisher
Elsevier BV
Online
2021-06-24
DOI
10.1016/j.cbpa.2021.05.006

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now